Eaton Vance Management Bridge Bio Pharma, Inc. Transaction History

Eaton Vance Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.21 - $12.14 $228,432 - $532,278	-43,845 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.34 - $17.16 $321,822 - $752,380	43,845 New	43,845 $445,000
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $5,542 - $26,010	-487 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $22,825 - $31,284	487 New	487 $0
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $232 - $319	-5 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $277 - $361	5 New	5 $0

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.45B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.